Covista Inc. vs Laureate Education, Inc., two Education stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CVSA and LAUR diverge most: on debt / equity, CVSA reads 0.46 and LAUR reads 0.14; on operating margin, CVSA reads 19.0% and LAUR reads 36.3%. The rest of the comparable metrics sit closer together. What CVSA's price implies is a bet that sits within the historical range (whole-company basis). What LAUR's price implies is a bet that sits within the historical range (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | CVSA | LAUR |
|---|---|---|
| Price | $129.69 | $39.48 |
| Market cap | $4.4B | $5.5B |
| Sector | Education | Education |
| Stage | Mature | Growth |
| P/E | 18.4 | 17.9 |
| P/B | 3.05 | 4.84 |
| P/S | 2.26 | 3.02 |
| EV/EBITDA | 10.7 | 12.4 |
| Revenue growth | +9.3% | +17.3% |
| Operating margin | 19.0% | 36.3% |
| Net margin | 12.9% | 17.6% |
| Return on equity | 17.4% | 28.2% |
| Return on assets | 8.3% | 13.3% |
| Return on invested capital | 14.8% | 27.0% |
| FCF yield | 8.9% | 5.2% |
| Debt / equity | 0.46 | 0.14 |
| Current ratio | 1.09 | 0.71 |
| Altman Z (solvency) | 3.87 | 3.80 |
| Piotroski F (quality) | 5 / 9 | 7 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.